Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis
British Journal of Dermatology, 11/02/09
Naldi L et al. – Despite the increased number of new options, the number of head–to–head comparative trials has decreased and most trials focus on short–term effects, probably reflecting the increased influence of industrial sponsorship on the research agenda.
Related Articles
Pediatric psoriasis: an update
Therapeutics and Clinical Risk Management, 10/22/09
Relevance Score: 95%
FDA Approves New Drug to Treat Psoriasis
Internet Source, 11/02/09
Relevance Score: 91%
Study shows major burden of psoriasis
Internet Source, 10/29/09
Relevance Score: 91%
Prevalence of myocardial infarction in patients with psoriasis in central China
Journal of the European Academy of Dermatology and Venereology, 10/27/09
Relevance Score: 91%
Why nail psoriasis remains difficult to treat
Dermatology in Practice, 10/12/09
Relevance Score: 91%
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Delayed wound healing in elderly people
Reviews in Clinical Gerontology, 12/15/09
Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy
Journal of the National Cancer Institute, 12/15/09
Expression of DNA mismatch repair proteins and MSH2 polymorphisms in nonmelanoma skin cancers of organ transplant recipients
British Journal of Dermatology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


